UB Paderborn / Katalog / Suche / in CDI

1 – 25 von 757

Sortiert nach

Checkpoint inhibition through small molecule-induced internalization of programmed death-ligand 1

Nature communications, 2021-02, Vol.12 (1), p.1222-1222, Article 1222

2021

Volltextzugriff (PDF)

Modulators of HBV capsid assembly as an approach to treating hepatitis B virus infection

Current opinion in pharmacology, 2016-10, Vol.30, p.131-137

Cole, Andrew G

2016

Volltextzugriff (PDF)

Preclinical Antiviral and Safety Profiling of the HBV RNA Destabilizer AB-161

Viruses, 2024-02, Vol.16 (3), p.323

2024

Volltextzugriff (PDF)

Structure–Activity Relationships and Discovery of (S)‑6-Isopropyl-2-methoxy-3-(3-methoxypropoxy)-10-oxo-5,10-dihydro‑6H‑pyrido[1,2‑h][1,7]naphthyridine-9-carboxylic Acid (AB-452), a Novel Orally Available HBV RNA Destabilizer

Journal of medicinal chemistry, 2024-01, Vol.67 (2), p.1421-1446

2024

Volltextzugriff (PDF)

Host Poly(A) Polymerases PAPD5 and PAPD7 Provide Two Layers of Protection That Ensure the Integrity and Stability of Hepatitis B Virus RNA

Journal of virology, 2021-08, Vol.95 (18), p.e0057421-e0057421

2021

Volltextzugriff (PDF)

Structure-Activity Relationships and Discovery of ( S )-6-Isopropyl-2-methoxy-3-(3-methoxypropoxy)-10-oxo-5,10-dihydro-6 H -pyrido[1,2- h ][1,7]naphthyridine-9-carboxylic Acid (AB-452), a Novel Orally Available HBV RNA Destabilizer

Journal of medicinal chemistry, 2024-01, Vol.67 (2), p.1421-1446

2024

Volltextzugriff (PDF)

Design, synthesis, and structure-activity relationship of a bicyclic HBV capsid assembly modulator chemotype leading to the identification of clinical candidate AB-506

Bioorganic & medicinal chemistry letters, 2023-10, Vol.94, p.129456, Article 129456

2023

Volltextzugriff (PDF)

Preclinical Profile of AB-423, an Inhibitor of Hepatitis B Virus Pregenomic RNA Encapsidation

Antimicrobial agents and chemotherapy, 2018-06, Vol.62 (6)

2018

Volltextzugriff (PDF)

Preclinical characterization of AB-506, an inhibitor of HBV replication targeting the viral core protein

Antiviral research, 2022-01, Vol.197, p.105211-105211, Article 105211

2022

Volltextzugriff (PDF)

Identification of CXCR3 receptor agonists in combinatorial small-molecule libraries

Biochemical and biophysical research communications, 2006-10, Vol.349 (1), p.221-228

2006

Volltextzugriff (PDF)

Synthesis and SAR studies of novel benzodiazepinedione-based inhibitors of Clostridium difficile (C. difficile) toxin B (TcdB)

Bioorganic & medicinal chemistry letters, 2018-12, Vol.28 (23-24), p.3601-3605

2018

Volltextzugriff (PDF)

The identification of highly efficacious functionalised tetrahydrocyclopenta[]pyrroles as inhibitors of HBV viral replication through modulation of HBV capsid assembly

RSC medicinal chemistry, 2022-03, Vol.13 (3), p.343-349

2022

Volltextzugriff (PDF)

Discovery of C‑Linked Nucleoside Analogues with Antiviral Activity against SARS-CoV‑2

ACS infectious diseases, 2024-05, Vol.10 (5), p.1780-1792

2024

Volltextzugriff (PDF)

Small molecule chemokine mimetics suggest a molecular basis for the observation that CXCL10 and CXCL11 are allosteric ligands of CXCR3

British journal of pharmacology, 2012-06, Vol.166 (3), p.912-923

2012

Volltextzugriff (PDF)

Novel, potent, selective, and metabolically stable stearoyl-CoA desaturase (SCD) inhibitors

Bioorganic & medicinal chemistry letters, 2009-04, Vol.19 (7), p.2048-2052

2009

Volltextzugriff (PDF)

Aminopurine based JNK inhibitors for the prevention of ischemia reperfusion injury

Bioorganic & medicinal chemistry letters, 2012-02, Vol.22 (3), p.1427-1432

2012

Volltextzugriff (PDF)

Synthesis of 2-amino-5-benzoyl-4-(2-furyl)thiazoles as adenosine A(2A) receptor antagonists

Bioorganic & medicinal chemistry letters, 2009-01, Vol.19 (2), p.378-381

2009

Volltextzugriff (PDF)

Synthesis of 2-amino-5-benzoyl-4-(2-furyl)thiazoles as adenosine A2A receptor antagonists

Bioorganic & medicinal chemistry letters, 2009-01, Vol.19 (2), p.378-381

2009

Volltextzugriff (PDF)

Orally bioavailable, liver-selective stearoyl-CoA desaturase (SCD) inhibitors

Bioorganic & medicinal chemistry letters, 2009-06, Vol.19 (11), p.3050-3053

2009

Volltextzugriff (PDF)

Synthesis of novel substituted 3,8,11-triazaspiro[5,6]dodecan-7-ones

Tetrahedron letters, 2011-02, Vol.52 (8), p.849-852

2011

Volltextzugriff (PDF)

Discovery of 2-aminoimidazopyridine adenosine A(2A) receptor antagonists

Bioorganic & medicinal chemistry letters, 2010-11, Vol.20 (22), p.6845-6849

2010

Volltextzugriff (PDF)

Discovery of 2-aminoimidazopyridine adenosine A2A receptor antagonists

Bioorganic & medicinal chemistry letters, 2010-11, Vol.20 (22), p.6845-6849

2010

Volltextzugriff (PDF)

Synthesis and SAR studies of trisubstituted purinones as potent and selective adenosine A2A receptor antagonists

Bioorganic & medicinal chemistry letters, 2009-03, Vol.19 (5), p.1399-1402

2009

Volltextzugriff (PDF)

2-Benzimidazolyl-9-(chroman-4-yl)-purinone derivatives as JAK3 inhibitors

Bioorganic & medicinal chemistry letters, 2009-12, Vol.19 (23), p.6788-6792

2009

Volltextzugriff (PDF)

Identification and initial evaluation of 4- N-aryl-[1,4]diazepane ureas as potent CXCR3 antagonists

Bioorganic & medicinal chemistry letters, 2006, Vol.16 (1), p.200-203

2006

Volltextzugriff (PDF)

1 – 25 von 757

Suche als RSS-Feed

Suchergebnisse filtern

Filter anzeigen

Nur zeigen

Geprüft (Peer-Review)
(692)
Mit Volltextzugriff
(675)

Publikationsform

2 weitere anzeigen...

Weniger anzeigen...

Sprache

Erscheinungsjahr

n.n

Thema

Science & Technology
(538)
Life Sciences & Biomedicine
(429)
Humans
(358)
Female
(202)
Male
(176)
Biological And Medical Sciences
(116)
Adult
(114)
Medical Sciences
(98)
Middle Aged
(98)
Animals
(93)
Physical Sciences
(83)
Aged
(68)
Neurosciences & Neurology
(61)
Child
(59)
Adolescent
(56)
General & Internal Medicine
(56)
Clinical Neurology
(52)
Surgery
(47)
Science & Technology - Other Topics
(43)
Genetics & Heredity
(42)

15 weitere anzeigen...

Weniger anzeigen...

Zeitschrift / Serie

Bioorganic & Medicinal Chemistry Letters
(20)
Genetics In Medicine
(15)
Blood
(12)
Alzheimer's & Dementia
(11)
Nature
(11)
Nature Communications
(11)
Cancer Research
(9)
American Journal Of Human Genetics
(8)
Journal Of Physical Chemistry. C
(8)
Neurology
(8)

5 weitere anzeigen...

Weniger anzeigen...

Neu hinzugefügt

... seit 30 Tagen
(3)
... seit 90 Tagen
(7)

Menü

Weitere Dienste

Einstellungen

Checkpoint inhibition through small molecule-induced internalization of programmed death-ligand 1

Modulators of HBV capsid assembly as an approach to treating hepatitis B virus infection

Preclinical Antiviral and Safety Profiling of the HBV RNA Destabilizer AB-161

Structure–Activity Relationships and Discovery of (S)‑6-Isopropyl-2-methoxy-3-(3-methoxypropoxy)-10-oxo-5,10-dihydro‑6H‑pyrido[1,2‑h][1,7]naphthyridine-9-carboxylic Acid (AB-452), a Novel Orally Available HBV RNA Destabilizer

Host Poly(A) Polymerases PAPD5 and PAPD7 Provide Two Layers of Protection That Ensure the Integrity and Stability of Hepatitis B Virus RNA

Structure-Activity Relationships and Discovery of ( S )-6-Isopropyl-2-methoxy-3-(3-methoxypropoxy)-10-oxo-5,10-dihydro-6 H -pyrido[1,2- h ][1,7]naphthyridine-9-carboxylic Acid (AB-452), a Novel Orally Available HBV RNA Destabilizer

Design, synthesis, and structure-activity relationship of a bicyclic HBV capsid assembly modulator chemotype leading to the identification of clinical candidate AB-506

Preclinical Profile of AB-423, an Inhibitor of Hepatitis B Virus Pregenomic RNA Encapsidation

Preclinical characterization of AB-506, an inhibitor of HBV replication targeting the viral core protein

Identification of CXCR3 receptor agonists in combinatorial small-molecule libraries

Synthesis and SAR studies of novel benzodiazepinedione-based inhibitors of Clostridium difficile (C. difficile) toxin B (TcdB)

The identification of highly efficacious functionalised tetrahydrocyclopenta[]pyrroles as inhibitors of HBV viral replication through modulation of HBV capsid assembly

Discovery of C‑Linked Nucleoside Analogues with Antiviral Activity against SARS-CoV‑2

Small molecule chemokine mimetics suggest a molecular basis for the observation that CXCL10 and CXCL11 are allosteric ligands of CXCR3

Novel, potent, selective, and metabolically stable stearoyl-CoA desaturase (SCD) inhibitors

Aminopurine based JNK inhibitors for the prevention of ischemia reperfusion injury

Synthesis of 2-amino-5-benzoyl-4-(2-furyl)thiazoles as adenosine A(2A) receptor antagonists

Synthesis of 2-amino-5-benzoyl-4-(2-furyl)thiazoles as adenosine A2A receptor antagonists

Orally bioavailable, liver-selective stearoyl-CoA desaturase (SCD) inhibitors

Synthesis of novel substituted 3,8,11-triazaspiro[5,6]dodecan-7-ones

Discovery of 2-aminoimidazopyridine adenosine A(2A) receptor antagonists

Discovery of 2-aminoimidazopyridine adenosine A2A receptor antagonists

Synthesis and SAR studies of trisubstituted purinones as potent and selective adenosine A2A receptor antagonists

2-Benzimidazolyl-9-(chroman-4-yl)-purinone derivatives as JAK3 inhibitors

Identification and initial evaluation of 4- N-aryl-[1,4]diazepane ureas as potent CXCR3 antagonists

Suchergebnisse filtern